1Yeo HL, Paty PB. Management of recurrent rectal eancer:practical in- sights in planning and surgical intervention [ J ]. J Surg Oncol,2014, 109( l ) :47-52.
2Avradopoulos KA, Vezeridis MP, Wanebo HJ. Pelvic exenteration for recurrent rectal cancer[ J ]. Adv Surg, 1996,29:215-233.
3Varker KA, Wanebo HJ. Salvage of pelvic recurrence of colorectal cancer[J]. J Surg Oncol, 2010,101 ( 8 ) :649-660.
4Brush J, Boyd K, Chappell F, et al. The value of FDG positron emis- sion tomography/computerised tomography(PET/CT) in pre-operative staging of colorectal cancer:a systematic review and economic evalua- tion[J]. Health Technol Assess ,2011,15 ( 35 ) : 1-192.
5Moore HG,Akhurst T,Larson SM,et al. A case-controlled sludy of 18- fluorodeoxyglucose positron emission tomography in the detection of pelvic recurrence in previously irradiated rectal cancer patients [ J ]. J Am Coll Surg,2003,197(1) :22-28.
6Whiteford MH,Whiteford HM,Yee LF, et al. Usefulness of FDG-PET scan in the assessment of suspected metastatic or recurrent adenocarci- noma of the colon and rectum [ J]. Dis Colon Rectum, 2000,43 (6) : 759-767.
7Suzuki K, Dozois RR, Devine RM, et al. Curative reoperations for lo- cally recurrent rectal cancer [J]. Dis Colon Rectum, 1996,39 ( 7 ) : 730-736.
8Valentini V,Morganti AG, Gambacorta MA, et al. Preoperative hyper- fractionated chemoradiation for locally recurrent rectal cancer in pa- tients previously irradiated to the pelvis:A multicentric phase II study [ J ]. Int J Radiat Oncol Biol Phys ,2006,64 (4) :1129-1139.
9Calvo FA,Gómez-Espl M, Diaz-González JA, et al. Intraoperative pre- sacral electron boost following preoperative chemoradiation in 3B-4Nx rectal cancer:initial local effects and clinical outcome analysis[ J]. Radiother Onco1,2002,62 ( 2 ) :201-206.
10Shoup M, Guillem JG, Alektiar KM, et al. Predictors of survival in re- current rectal cancer after resection and intraoperative radiotherapy [ J ]. Dis Colon Rectum,2002,45 ( 5 ) : 585-592.
